Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youfeng Yang

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Scientific Reports|February 14, 2015
S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinasePulin Che, Youfeng Yang, Xiaosi Han, et al.
Pulmonary Therapy|November 18, 2025
Double-Blind Randomized Placebo-Controlled Trial of a Lactobacillus Probiotic Blend in Chronic Obstructive Pulmonary DiseaseTeodora Nicola, Nancy M Wenger, Kara Seidman, et al.
Journal of the National Cancer Institute|January 1, 2016
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster DeliveryNeetu Saxena, Nunziata Maio, Daniel R Crooks, et al.
Cancer Genetics and Cytogenetics|December 8, 2009
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancerYoufeng Yang, Vladimir A Valera, Hesed M Padilla-Nash, et al.
Genes, Chromosomes & Cancer|April 8, 2020
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatmentsDarmood Wei, Youfeng Yang, Christopher J Ricketts, et al.
Genes, Chromosomes & Cancer|July 25, 2017
Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276)Youfeng Yang, Cathy D Vocke, Christopher J Ricketts, et al.
Hepatology (Baltimore, Md.)|June 11, 2015
Alternative splicing of the cell fate determinant Numb in hepatocellular carcinomaYinying Lu, Wanping Xu, Junfang Ji, et al.
Cancer Cell|September 13, 2011
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levelsWing-Hang Tong, Carole Sourbier, Gennady Kovtunovych, et al.
Genes, Chromosomes & Cancer|February 2, 2021
Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell linesYoufeng Yang, Christopher J Ricketts, Cathy D Vocke, et al.
Frontiers in Oncology|February 28, 2022
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell CarcinomaJill W Ford, Marieli Gonzalez-Cotto, Alexander W MacFarlane, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Scientific Reports|February 14, 2015
S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinasePulin Che, Youfeng Yang, Xiaosi Han, et al.
Pulmonary Therapy|November 18, 2025
Double-Blind Randomized Placebo-Controlled Trial of a Lactobacillus Probiotic Blend in Chronic Obstructive Pulmonary DiseaseTeodora Nicola, Nancy M Wenger, Kara Seidman, et al.
Journal of the National Cancer Institute|January 1, 2016
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster DeliveryNeetu Saxena, Nunziata Maio, Daniel R Crooks, et al.
Cancer Genetics and Cytogenetics|December 8, 2009
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancerYoufeng Yang, Vladimir A Valera, Hesed M Padilla-Nash, et al.
Genes, Chromosomes & Cancer|April 8, 2020
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatmentsDarmood Wei, Youfeng Yang, Christopher J Ricketts, et al.
Genes, Chromosomes & Cancer|July 25, 2017
Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276)Youfeng Yang, Cathy D Vocke, Christopher J Ricketts, et al.
Hepatology (Baltimore, Md.)|June 11, 2015
Alternative splicing of the cell fate determinant Numb in hepatocellular carcinomaYinying Lu, Wanping Xu, Junfang Ji, et al.
Cancer Cell|September 13, 2011
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levelsWing-Hang Tong, Carole Sourbier, Gennady Kovtunovych, et al.
Genes, Chromosomes & Cancer|February 2, 2021
Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell linesYoufeng Yang, Christopher J Ricketts, Cathy D Vocke, et al.
Frontiers in Oncology|February 28, 2022
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell CarcinomaJill W Ford, Marieli Gonzalez-Cotto, Alexander W MacFarlane, et al.
Pageof 7